RecallDepth
Class II Ongoing

Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-047-88.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
October 28, 2025
Posted
November 5, 2025
Recall Number
D-0145-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Princeton, NJ, United States

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.

Distribution

U.S Nationwide.

Lot / Code Info

Lot #: AD42469, Expiry: 2/28/2026; AD48707, Expiry:4/30/2026.

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls